Takeda Pharmaceutical Income Statement (2017-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	7.67B	7.93B	8.37B	7.52B	7.26B	7.76B	8.00B	7.72B	22.25B	7.11B	8.15B	7.76B	23.65B	6.93B	7.92B	7.65B	23.95B	7.11B	7.78B	7.65B
Cost of Revenue (Quarter)	2.51B	2.48B	2.52B	2.26B	2.21B	2.38B	2.43B	2.34B	7.23B	2.59B	2.61B	2.49B	8.03B	2.52B	2.54B	2.66B	8.13B	2.64B	2.59B	2.55B
Gross Profit (Quarter)	5.17B	5.45B	5.85B	5.39B	15.47B	4.58B	5.58B	5.10B	15.02B	4.52B	5.54B	5.02B	15.62B	4.42B	5.38B	5.40B	15.81B	4.48B	5.19B	5.10B
Operating items
Amortization - Intangibles (Quarter)				-0.96B	-2.68B	-0.81B	-0.93B	-0.95B	-2.68B	-0.91B	-0.94B	-0.89B	-2.76B	-0.90B	-0.91B	-0.96B	-2.79B	-0.89B	-0.82B
Research & Development (Quarter)	-1.20B	-1.13B	-1.24B	-1.11B	-1.12B	-1.24B	-1.23B	-1.19B	-1.27B	-1.27B	8.53B	-1.08B	-1.18B	-1.12B	8.16B	-0.99B	-1.10B	-1.14B	7.37B	-1.05B
Selling, General & Administrative (Quarter)	-1.93B	-2.03B	-1.99B	-1.79B	-1.80B	-1.86B	-1.88B	-1.81B	-1.75B	-1.81B	5.76B	-1.73B	-1.80B	-1.78B	5.76B	-1.77B	-1.72B	-1.84B	5.21B	-1.80B
Other Operating Expenses (Quarter)				0.98B	-2.46B	1.29B	1.23B	1.15B	-2.30B	1.15B	-16.11B	1.09B	-2.45B	0.95B	-15.69B	0.91B	-2.67B	1.05B	-14.41B
Operating Expenses (Quarter)	-3.12B	-3.16B	-3.23B	-1.92B	-5.38B	-1.80B	-1.88B	-1.85B	-5.32B	-1.93B	-1.82B	-1.72B	-5.42B	-1.95B	-1.77B	-1.85B	-5.49B	-1.92B	-1.83B	-2.85B
Operating Income (Quarter)	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.28B	2.87B	-2.70B	1.28B	1.26B
EBIT (Quarter)	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.28B	2.87B	-2.70B	1.28B	1.26B
Non-operating items
Interest & Investment Income (Quarter)	0.06B	0.04B	-0.17B	0.47B	0.11B	0.30B	0.46B	0.19B	0.38B	0.09B	0.21B	0.20B	0.31B	0.12B	0.48B	0.51B	1.40B	0.12B	0.47B	0.15B
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)			-0.22B				-0.25B
Net income details
EBT (Quarter)	0.56B	0.64B	1.92B	1.20B	0.47B	0.76B	1.18B	0.99B	2.27B	0.32B	0.92B	0.88B	1.89B	-0.71B	0.99B	1.04B	2.12B	-2.96B	1.04B	1.02B
Tax Provisions (Quarter)	-0.14B	-0.13B	-0.73B	-0.39B	-0.02B	0.08B	-0.38B	-0.33B	0.32B	0.30B	-0.31B	-0.27B	-0.48B	0.29B	-0.27B	-0.18B	-0.65B	0.56B	-0.32B	-0.31B
Profit After Tax (Quarter)	0.42B	0.51B	1.18B	0.81B	0.45B	0.84B	0.79B	0.65B	1.98B	0.21B	0.64B	0.61B	1.42B	-0.68B	0.81B	0.86B	1.47B	-2.39B	0.79B	0.71B
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B		0.00B	-0.00B		-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B
Income from Continuing Operations (Quarter)	0.70B	0.76B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	1.94B	0.02B	1.23B	1.14B	2.37B	-1.00B	1.26B	1.22B	2.78B	-3.52B	1.35B	1.33B
Consolidated Net Income (Quarter)	0.70B	0.76B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	1.94B	0.02B	1.23B	1.14B	2.37B	-1.00B	1.26B	1.22B	2.78B	-3.52B	1.35B	1.33B
Income towards Parent Company (Quarter)	0.42B	0.51B	-0.10B	0.81B	0.45B	0.84B	0.79B	0.65B	1.98B	0.21B	0.64B	0.61B	1.42B	-0.68B	0.81B	0.86B	1.47B	-2.39B	0.79B	0.71B
Net Income towards Common Stockholders (Quarter)	0.42B	0.51B	-0.10B	0.81B	0.45B	0.84B	0.79B	0.65B	1.98B	0.21B	0.64B	0.61B	1.42B	-0.68B	0.81B	0.86B	1.47B	-2.39B	0.79B	0.71B
Additional items
EPS (Basic) (Quarter)	0.27	0.32	-0.06	0.53	0.29	0.54	0.51	0.42	1.26	0.13	0.41	0.39	0.90	-0.43	0.52	0.54	0.93	-1.52	0.50	0.45
EPS (Diluted) (Quarter)	0.26	0.32	-0.06	0.52	0.29	0.54	0.51	0.42	1.26	0.13	0.41	0.39	0.88	-0.42	0.51	0.53	0.92	-1.50	0.50	0.45
Shares Outstanding (Quarter)	1.57B	1.57B	1.56B	1.55B	1.55B	1.55B	1.55B	1.55B	1.57B	1.57B	1.56B	1.56B	1.58B	1.58B	1.58B	1.58B	1.57B	1.57B	1.58B	1.58B
Shares Outstanding (Diluted) (Quarter)	1.58B	1.58B	1.58B	1.55B	1.56B	1.57B	1.57B	1.57B	1.57B	1.59B	1.58B	1.58B	1.60B	1.60B	1.61B	1.61B	1.60B	1.60B	1.58B	1.58B
Shares Outstanding (Entity) (Quarter)	0.16B	0.16B	0.12B	0.12B	0.12B	0.12B	0.14B	0.14B	0.14B	0.14B	0.12B		0.12B		0.12B		0.12B		0.14B
EBITDA (Quarter)	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.28B	2.87B	-2.70B	1.28B	1.26B
Interest Expenses (Quarter)	-0.95B	-1.26B	1.05B	-0.43B	-0.79B	-0.90B	0.88B	-0.43B	-0.73B	-1.17B	0.81B	-0.38B	-0.86B	-1.05B	0.90B	-0.74B	-2.13B	-0.53B	-0.68B	-0.40B
Tax Rate (Quarter)	-25.15%	-19.91%	-38.25%	-32.45%	-4.36%	11.20%	-32.48%	-33.79%	14.33%	92.90%	-33.38%	-30.24%	-25.18%	-41.47%	-27.42%	-17.49%	-30.83%	-19.03%	-30.42%	-30.40%

Research Tools

Datasets

Plans

Developers

Takeda Pharmaceutical TKPHF Income Statement (2017-2026)

Research Tools

Datasets

Plans

Developers

Takeda Pharmaceutical TKPHF Income Statement (2017-2026)

Create an account

Sign In

Reset Password